Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Transcriptional changes in canine distemper virus-induced demyelinating leukoencephalitis favor a biphasic mode of demyelination.
Cognitive deficits in pediatric-onset multiple sclerosis: what does the future hold?
Orientational ordering of carotenoids in myelin membranes resolved by polarized Raman microspectroscopy.
Simvastatin in patients with progressive multiple sclerosis.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
[Side-effects of the treatment with disease modifying drugs in patients with multiple sclerosis: an analysis of register data in the Yaroslavl region.]
Cell-Based Reporter Gene Assay for Therapy-Induced Neutralizing Antibodies to Interferon-Beta in Multiple Sclerosis.
Early presentation of neuromyelitis optica.
Removal of access to alemtuzumab for patients with aggressive multiple sclerosis.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.
Devic's disease before Devic: Bilateral optic neuritis and simultaneous myelitis in a young woman (1874).
Detection of mycobacterium avium subsp. paratuberculosis in cheeses from small ruminants in Tuscany.
Multiple sclerosis databases: present and future.
STAT5 programs a distinct subset of GM-CSF-producing T helper cells that is essential for autoimmune neuroinflammation.
Fall Incidence as the Primary Outcome in Multiple Sclerosis Falls-Prevention Trials: Recommendation from the International MS Falls Prevention Research Network.
Neuromyelitis optica in a child with Aicardi-Goutières syndrome.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.
Hydrocephalus in neuromyelitis optica.
A Comparison of Supervised Machine Learning Algorithms and Feature Vectors for MS Lesion Segmentation Using Multimodal Structural MRI.
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Pages
« first
‹ previous
…
361
362
363
364
365
366
367
368
369
…
next ›
last »